Guided Therapeutics (GTHP) Research & Development (2010 - 2026)
Guided Therapeutics (GTHP) posted Research & Development of $323000.0 for Q4 2025, up 137.5% sequentially from $136000.0 in Q3 2025, and up 426.26% YoY from $61376.2 in Q4 2024.
Guided Therapeutics (GTHP) Research & Development (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Research & Development for 16 years, with the latest figure at $323000.0 in Q4 2025.
- Quarterly Research & Development rose 426.26% year-over-year to $323000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $666000.0 (up 116.94% YoY) and the FY2025 annual result came in at $469000.0, up 63.41% from the prior year.
- Research & Development advanced to $323000.0 in Q4 2025 per GTHP's latest filing, from $136000.0 in the prior quarter.
- Over five years, Research & Development peaked at $323000.0 in Q4 2025 and troughed at -$99000.0 in Q4 2024.
- A 5-year average of $72000.0 and a median of $67000.0 in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2024: Research & Development surged 762.5% in 2023, then slumped 252.31% in 2024.
- Over 5 years, Research & Development stood at $89000.0 in 2021, then sank by 158.43% to -$52000.0 in 2022, then jumped by 225.0% to $65000.0 in 2023, then plunged by 252.31% to -$99000.0 in 2024, then jumped by 426.26% to $323000.0 in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $323000.0, $136000.0, and $133000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34,000.00 |
| Dec 31, 2025 | 323,000.00 |
| Sep 30, 2025 | 136,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | -99,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 73,000.00 |
| Dec 31, 2022 | -52,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 89,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 20,000.00 |